Cargando…

Fibrinolytic Changes in Women with Preeclampsia

OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with...

Descripción completa

Detalles Bibliográficos
Autores principales: Godtfredsen, Anne Cathrine, Sidelmann, Johannes Jakobsen, Dolleris, Britta Blume, Jørgensen, Jan Stener, Johansen, Emma Kathrine Jungjohan, Pedersen, Melissa Fernard Bøg, Palarasah, Yaseelan, Gram, Jørgen Brodersen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558852/
https://www.ncbi.nlm.nih.gov/pubmed/36217728
http://dx.doi.org/10.1177/10760296221126172
_version_ 1784807534369964032
author Godtfredsen, Anne Cathrine
Sidelmann, Johannes Jakobsen
Dolleris, Britta Blume
Jørgensen, Jan Stener
Johansen, Emma Kathrine Jungjohan
Pedersen, Melissa Fernard Bøg
Palarasah, Yaseelan
Gram, Jørgen Brodersen
author_facet Godtfredsen, Anne Cathrine
Sidelmann, Johannes Jakobsen
Dolleris, Britta Blume
Jørgensen, Jan Stener
Johansen, Emma Kathrine Jungjohan
Pedersen, Melissa Fernard Bøg
Palarasah, Yaseelan
Gram, Jørgen Brodersen
author_sort Godtfredsen, Anne Cathrine
collection PubMed
description OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed. RESULTS: Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p  =  0.0004 p  =  0.04, p  =  0.03, p < 0.0001 respectively. CONCLUSION: This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy.
format Online
Article
Text
id pubmed-9558852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-95588522022-10-14 Fibrinolytic Changes in Women with Preeclampsia Godtfredsen, Anne Cathrine Sidelmann, Johannes Jakobsen Dolleris, Britta Blume Jørgensen, Jan Stener Johansen, Emma Kathrine Jungjohan Pedersen, Melissa Fernard Bøg Palarasah, Yaseelan Gram, Jørgen Brodersen Clin Appl Thromb Hemost Original Manuscript OBJECTIVES: Preeclampsia (PE) is a serious complication of pregnancy. The fibrinolytic system play crucial roles regarding placentation and evolution of PE. AIM: To study comprehensively components of the fibrinolytic system and fibrin lysability in women with PE. DESIGN AND METHODS: 117 women with PE and matched controls were included. Tissue type plasminogen activator (t-PA), plasminogen, PAI-1, plasmin inhibitor (PI), D-dimer, the fibrinolytic potential of dextran sulphate euglobulin fraction (DEF), PAI-2, polymere PAI-2, fibrin clot lysability, thrombin activatable fibrinolysis inhibitor (TAFI) and fibrinogen were assessed. RESULTS: Women with PE had significantly increased concentrations of t-PA and PAI-1, whereas the plasma concentration of PAI-2 was significantly lower compared to controls, p < 0.0001. Polymere PAI-2 was detected in both groups. DEF, TAFI and fibrinogen were not different between the groups. D-dimer was significantly increased and plasminogen/PI together with fibrin clot lysability time decreased in the PE-group, p  =  0.0004 p  =  0.04, p  =  0.03, p < 0.0001 respectively. CONCLUSION: This study demonstrates that PE is associated with an affected t-PA/PAI-1 system, decreased PAI-2 and increased fibrin lysability. Furthermore, PAI-2 has the potential to polymerize during pregnancy. SAGE Publications 2022-10-11 /pmc/articles/PMC9558852/ /pubmed/36217728 http://dx.doi.org/10.1177/10760296221126172 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Manuscript
Godtfredsen, Anne Cathrine
Sidelmann, Johannes Jakobsen
Dolleris, Britta Blume
Jørgensen, Jan Stener
Johansen, Emma Kathrine Jungjohan
Pedersen, Melissa Fernard Bøg
Palarasah, Yaseelan
Gram, Jørgen Brodersen
Fibrinolytic Changes in Women with Preeclampsia
title Fibrinolytic Changes in Women with Preeclampsia
title_full Fibrinolytic Changes in Women with Preeclampsia
title_fullStr Fibrinolytic Changes in Women with Preeclampsia
title_full_unstemmed Fibrinolytic Changes in Women with Preeclampsia
title_short Fibrinolytic Changes in Women with Preeclampsia
title_sort fibrinolytic changes in women with preeclampsia
topic Original Manuscript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558852/
https://www.ncbi.nlm.nih.gov/pubmed/36217728
http://dx.doi.org/10.1177/10760296221126172
work_keys_str_mv AT godtfredsenannecathrine fibrinolyticchangesinwomenwithpreeclampsia
AT sidelmannjohannesjakobsen fibrinolyticchangesinwomenwithpreeclampsia
AT dollerisbrittablume fibrinolyticchangesinwomenwithpreeclampsia
AT jørgensenjanstener fibrinolyticchangesinwomenwithpreeclampsia
AT johansenemmakathrinejungjohan fibrinolyticchangesinwomenwithpreeclampsia
AT pedersenmelissafernardbøg fibrinolyticchangesinwomenwithpreeclampsia
AT palarasahyaseelan fibrinolyticchangesinwomenwithpreeclampsia
AT gramjørgenbrodersen fibrinolyticchangesinwomenwithpreeclampsia